What Factors Are Driving Growth in the Global Promacta Market?

added blog Other

2026-03-16 07:25:23 -

The Promacta Market is witnessing increasing global demand due to the rising prevalence of blood-related disorders and the expanding role of targeted hematology therapies. The Promacta (eltrombopag) market was valued at USD 2,216 Million in 2024 and is projected to grow to USD 2,802 Million by 2030, with a compound annual growth rate (CAGR) of 4.9% from 2025 to 2030. Growing adoption of...

0 Comments 0 Shares 38 Views 0 Reviews